BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30830684)

  • 1. Breast cancer cell motility is promoted by 14-3-3γ.
    Hiraoka E; Mimae T; Ito M; Kadoya T; Miyata Y; Ito A; Okada M
    Breast Cancer; 2019 Sep; 26(5):581-593. PubMed ID: 30830684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma.
    Ito M; Hagiyama M; Mimae T; Inoue T; Kato T; Yoneshige A; Nakanishi J; Kondo T; Okada M; Ito A
    Breast Cancer Res Treat; 2014 Feb; 144(1):59-69. PubMed ID: 24496929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
    Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
    Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
    Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J
    BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New challenges in pseudopodial proteomics by a laser-assisted cell etching technique.
    Mimae T; Ito A
    Biochim Biophys Acta; 2015 Jun; 1854(6):538-46. PubMed ID: 25461796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.
    Raungrut P; Wongkotsila A; Champoochana N; Lirdprapamongkol K; Svasti J; Thongsuksai P
    Anticancer Res; 2018 Jun; 38(6):3507-3514. PubMed ID: 29848704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
    Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
    Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
    Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
    Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
    Wang Z; Liu Q; Chen Q; Zhu R; Zhu HG
    Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):333-8. PubMed ID: 16834906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-200b Impacts Breast Cancer Cell Migration and Invasion by Regulating Ezrin-Radixin-Moesin.
    Hong H; Yu H; Yuan J; Guo C; Cao H; Li W; Xiao C
    Med Sci Monit; 2016 Jun; 22():1946-52. PubMed ID: 27276064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
    Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
    Wu J; Liu S; Fan Z; Zhang L; Tian Y; Yang R
    Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
    Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
    Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARPC4 promotes bladder cancer cell invasion and is associated with lymph node metastasis.
    Xu N; Qu GY; Wu YP; Lin YZ; Chen DN; Li XD; Chen SH; Huang JB; Zheng QS; Xue XY; Wei Y
    J Cell Biochem; 2020 Jan; 121(1):231-243. PubMed ID: 31190401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
    Tiang JM; Butcher NJ; Minchin RF
    Cancer Med; 2015 Apr; 4(4):565-74. PubMed ID: 25627111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.
    Hijazi MM; Thompson EW; Tang C; Coopman P; Torri JA; Yang D; Mueller SC; Lupu R
    Int J Oncol; 2000 Oct; 17(4):629-41. PubMed ID: 10995872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion.
    Freitas VM; do Amaral JB; Silva TA; Santos ES; Mangone FR; Pinheiro Jde J; Jaeger RG; Nagai MA; Machado-Santelli GM
    Mol Cancer; 2013 Jan; 12():2. PubMed ID: 23289900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.